Literature DB >> 7443842

Metabolism of sennosides by human intestinal bacteria.

K Kobashi, T Nishimura, M Kusaka, M Hattori, T Namba.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7443842     DOI: 10.1055/s-2008-1074963

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


× No keyword cloud information.
  7 in total

Review 1.  Colonic drug delivery: prodrug approach.

Authors:  V R Sinha; R Kumria
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

2.  Efficacy of daiokanzoto in chronic constipation refractory to first-line laxatives.

Authors:  Tatsuya Hirose; Yasutaka Shinoda; Aya Yoshida; Machiko Kurimoto; Kouki Mori; Yuki Kawachi; Kouji Tanaka; Atsuko Takeda; Tomoaki Yoshimura; Tadashi Sugiyama
Journal:  Biomed Rep       Date:  2016-09-08

Review 3.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

4.  Isolation of a human intestinal anaerobe, Bifidobacterium sp. strain SEN, capable of hydrolyzing sennosides to sennidins.

Authors:  T Akao; Q M Che; K Kobashi; L Yang; M Hattori; T Namba
Journal:  Appl Environ Microbiol       Date:  1994-03       Impact factor: 4.792

5.  Promotion of intestinal peristalsis by Bifidobacterium spp. capable of hydrolysing sennosides in mice.

Authors:  Mitsuharu Matsumoto; Atsushi Ishige; Yuka Yazawa; Manami Kondo; Koji Muramatsu; Kenji Watanabe
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

6.  Gut Bacteria Selectively Altered by Sennoside A Alleviate Type 2 Diabetes and Obesity Traits.

Authors:  Zhonghong Wei; Peiliang Shen; Peng Cheng; Yin Lu; Aiyun Wang; Zhiguang Sun
Journal:  Oxid Med Cell Longev       Date:  2020-06-25       Impact factor: 6.543

7.  Daiokanzoto (Da-Huang-Gan-Cao-Tang) is an effective laxative in gut microbiota associated with constipation.

Authors:  Kento Takayama; Chiho Takahara; Norihiko Tabuchi; Nobuyuki Okamura
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.